---
type: "Symbol"
title: "Acrivon Therapeutics (ACRV.US) — Community Discussions"
description: "Community discussions about this stock, including analyst opinions, earnings analysis, and investment strategies from verified financial professionals and active investors."
locale: "en"
url: "https://longbridge.com/en/quote/ACRV.US/topics.md"
symbol: "ACRV.US"
parent: "https://longbridge.com/en/quote/ACRV.US.md"
count: 3
datetime: "2026-03-14T11:45:22.837Z"
locales:
  - [en](https://longbridge.com/en/quote/ACRV.US/topics.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/ACRV.US/topics.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/ACRV.US/topics.md)
---

# Acrivon Therapeutics (ACRV.US) — Community Discussions

### [$Acrivon Therapeutics(ACRV.US) cannot buy Longbrid…](https://longbridge.com/en/topics/35912323.md)

- Author: [认真冷静专注](https://longbridge.com/en/profiles/18951698.md)
- Datetime: 2025-11-03T10:26:57.000Z
- Comments: 0
- $Acrivon Therapeutics(ACRV.US) cannot buy Longbridge

### [$Acrivon Therapeutics(ACRV.US) Who placed the orde…](https://longbridge.com/en/topics/33729130.md)

- Author: [泽度金](https://longbridge.com/en/profiles/21052324.md)
- Datetime: 2025-09-08T10:13:23.000Z
- Comments: 0
- $Acrivon Therapeutics(ACRV.US) Who placed the order!

### [【涨幅排行榜】一月次新股涨幅排行榜](https://longbridge.com/en/topics/3936875.md)

- Author: [阿浦美股](https://longbridge.com/en/profiles/6844605.md)
- Datetime: 2023-02-07T02:02:34.000Z
- Comments: 0
- ————「一月次新股涨幅榜 TOP20」  评选标准 2023 年 1 月 1 日至 1 月 31 日截止，所有在美国证券市场上市的次新股一月股价涨幅评选。 * 次新股指自 IPO 发行日算起到首次解禁期时间内刚上市企业。  评选价值通过对新上市企业的市值增长、投资总额和涨幅反馈等因素的分析，可以更客观地反映出资本市场对于新上市企业的认可度和资金走向。根据涨幅榜反馈可以帮助会员更好地筛选优质企业.

## References

- [Acrivon Therapeutics (ACRV.US)](https://longbridge.com/en/quote/ACRV.US.md)


> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/ACRV.US/topics.md) | [繁體中文](https://longbridge.com/zh-HK/quote/ACRV.US/topics.md)